Regional Monitoring EECA
by ECUO PLWH
Showing 1-7 of 7 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDTenofovir disoproxil fumarate + LamivudinLamivudine+Tenofovir - FDC300mg tab0.173330305.215.22016YesYesYes
2Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDLamivudine+Tenofovir - FDC300mg tab0.173330305.215.22015Not specifiedNot specifiedNot specified
3Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.183345960305.515328426IDA FoundationNot specifiedNot specifiedNot specified
4Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.183322980305.576642132015Not specifiedNot specifiedNot specified
5Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.183322980305.57664213IDA Foundation2015Not specifiedNoNot specified
6Republic of MoldovaGovernmentRanbaxy Laboratories LimitedTenalemLamivudine+Tenofovir - FDC300mg tab0.226333840306.7911287659.12Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
7UkraineGovernmentHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.40735063703012.2216879206261.382015Not specifiedNot specifiedNot specified